← Back
$AVIR All transactions

Atea Pharmaceuticals, Inc.

A

$ Value

$0

Shares

29,600

Price

$0

Filed

Jun 24

Insider

Name

Murphy Polly A.

Title

CIK

0001829248

Roles

Director

Transaction Details

Transaction Date

2025-06-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

29,600

Footnotes

Restricted stock units convert into common stock on a one-for-one basis. | The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date. | The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date. | The restricted stock units were fully vested as of June 20, 2025

Filing Info

Accession No.

0000950170-25-089607

Form Type

4

Issuer CIK

0001593899

Murphy Polly A.'s History

Date Ticker Type Value
2025-06-20 AVIR M $0
2025-06-20 AVIR A $0
2025-06-20 AVIR A $0
2025-06-20 AVIR M $0
2025-05-28 CELC G $0
2025-05-28 CELC G $0
2025-05-19 CELC A $0
2024-06-24 CELC G $0
2024-06-24 CELC G $0
2024-06-24 CELC G $0

Other Insiders at AVIR (90d)

Insider Bought Sold Last
Sommadossi Jean-Pierre
President, CEO, and Chairman
2026-02-03
Corcoran Andrea
See Remarks
2026-03-11
Foster Wayne
EVP, Chief Accounting Officer
2026-01-31
Horga Maria Arantxa
Chief Medical Officer
2026-01-31
Vavricka John
Chief Commercial Officer
2026-01-31
Hammond Janet MJ
Chief Development Officer
2026-01-31